Artikel

Salwender, Hans ; Bertsch, Uta ; Weisel, Katja ; Duerig, Jan ; Kunz, Christina ; Benner, Axel ; Blau, Igor W. ; Raab, Marc Steffen ; Hillengass, Jens ; Hose, Dirk ; Huhn, Stefanie ; Hundemer, Michael ; Andrulis, Mindaugas ; Jauch, Anna ; Seidel-Glaetzer, Andrea ; Lindemann, Hans-Walter ; Hensel, Manfred ; Fronhoffs, Stefan ; Martens, Uwe ; Hansen, Timon ; Wattad, Mohammed ; Graeven, Ullrich ; Munder, Markus ; Fenk, Roland ; Haenel, Mathias ; Scheid, Christof ; Goldschmidt, Hartmut (2019) Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma. BMC Cancer, 19 (504). S. 1-11. ISSN 1471-2407